Secondary Logo

November/December 2018 - Volume 41 - Issue 9

  • Steven A. Rosenberg, MD, PhD
  • 1524-9557
  • 1537-4513
  • 9 issues per year
  • Oncology 79/217
    Immunology 55/150
    Medicine, Research, and Experimental 37/128
  • 3.826

Current Issue Highlights


The Hexavalent CD40 Agonist HERA-CD40L Induces T-Cell–mediated Antitumor Immune Response Through Activation of Antigen-presenting Cells

Merz, Christian; Sykora, Jaromir; Marschall, Viola; More

Journal of Immunotherapy. 41(9):385-398, November/December 2018.


Hemofiltration Successfully Eliminates Severe Cytokine Release Syndrome Following CD19 CAR-T-Cell Therapy

Liu, Yanfen; Chen, Xinfeng; Wang, Dao; More

Journal of Immunotherapy. 41(9):406-410, November/December 2018.